Mirodia Therapeutics is a NewCo whose mission is to develop topical disease-modifying regenerative medicines for olfactory loss / dysfunction (anosmia / hyposmia). Anosmia / hyposmia are associated with increased morbidity & mortality & represent a potentially new and significant category for which there are no approved disease-modifying therapeutics. Mirodia Therapeutics provides a unique opportunity to establish a leadership position in addressing this significant unmet clinical need.